29P Long-term performance of residual cancer burden (RCB): Clinical pathological stage (CPS) and CPS+ER+Grade (CPS-EG) models in ER+HER2- breast cancer (BC) patients (pts) after neoadjuvant chemotherapy (NAC) - Role of Ki67 drop and extended endocrine therapy (EET) | Publicación